Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drug Safety|January 6, 2026
Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction CheckersLelio Crupi, Louis Letinier, Vianney Jouhet, et al.
Journal of Clinical Medicine|November 27, 2024
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian CancerGiulia Spagnol, Sofia Bigardi, Michela Zorzi, et al.
Journal of the American Geriatrics Society|June 1, 2024
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysisMassimo Carollo, Salvatore Crisafulli, Giacomo Vitturi, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunitiesSalvatore Crisafulli, Francesco Ciccimarra, Chiara Bellitto, et al.
Clinical Epidemiology|June 10, 2024
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE ProjectAndrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, et al.
Expert Opinion on Biological Therapy|May 20, 2024
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database networkAndrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, et al.
Pharmacological Research|January 17, 2024
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE projectYlenia Ingrasciotta, Andrea Spini, Luca L'Abbate, et al.
Pharmacological Research|April 22, 2026
Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: a target trial emulation using the Italian VALORE distributed database networkAndrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, et al.
Pharmacological Research|June 30, 2025
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE projectChiara Bellitto, Ylenia Ingrasciotta, Federica Soardo, et al.
Pageof 3